Improve Clinical Outcomes for Your Diabetic Patients
Diagnose peripheral and cardiac neuropathy before it becomes symptomatic with autonomic nervous system (ANS) testing.
Peripheral and cardiovascular neuropathy are among the largest concerns for diabetic patients , and it has been repeatedly proven that the earlier this condition can be detected and treated, the more likely a patient is to live a long and healthy life. Current estimates put the likelihood that a diabetic patient showing physical symptoms of peripheral neuropathy will survive through the next five years at between only 25 and 50 percent. By catching this condition through regular testing, health care providers can make a positive difference.
Autonomic Nervous System testing require only minutes to set up and operate – the benefits for your patients last a lifetime. Also, with insurance billing codes that work with major private insurance, including Medicare, you can be sure that this is one solution that truly benefits your practice as well.
Benefits to Your Practice
- Easily interpreted and readable reports
- No skin punctures or biopsies
- Proven, reimbursable diagnosis codes for private insurance and Medicare
- Excellent opportunity to be a very lucrative add-on to any existing practice
- Minimal effort and training for staff
- Depending on the specific state insurance: reimbursement for the test ranges
- Testing just 2-3 patients a day would create an additional $ 11,000 – $25,000 in monthly revenue
- We can provide either a service model for offices who prefer a no cost start up or equipment purchase
- Easy financing options through AMS
How Does the Test Work?
The Autonomic Nervous System Testing equipment is easy to use and very mobile. It’s simply plugged in to the laptop provided through the USB port and runs through proprietary software.
Dependent on the equipment chosen, a rapid evaluation of sudomotor function is performed or sudomotor and heart rate variablility (HRV) and arterial elasticity.
The test is non invasive, has high patient acceptance and requires no specialized training to operate the equipment. The testing takes no longer than 7 minutes and provides valuable insights into patient health and wellness through the detailed information and the easy to interpret color coded report.
With ANS testing, sudomotor function is assessed and in addition the patient performs some simple breathing exercises that affect the HRV.The report enables the physician to determine any further testing required and course of treatment.
Testing patients when they are diagnosed with Type II diabetes and then at regular intervals in the following years can detect Sudomotor and Autonomic Dysfunction and greatly improve your patients’ clinical outcomes.
Start-Up and Implementation
How Do I Get Started?
Your Certified Ancillary Consultant will work with you to determine the best Autonomic Nervous System testing solution for your practice. If you would like to finance this equipment, AMS also offers easy equipment financing solutions.
Proven Reimbursement Codes
Suggested CPT Codes:
- 95921: Testing of autonomic nervous system function; cardiovagal innervations (parasympathetic function)
- 95923: The appropriate code for galvanic skin response
- 95943: has been established to report when an autonomic function testing does not include beat–to–beat recording, or for testing without the use of a tilt table. This is a simpler, automated procedure compared to the other autonomic codes.
- 93922: Ankle Brachial Index
- *Do not report 95943 in conjunction with 93040, 95921, 95922, and 95924
We are able to offer a ANS service that eliminates the need for purchase of the equipment to suitably qualified practices.
1) Determine if equipment or a service model is best for your practice.
2) Learn how to use your new equipment with our assistance. The test can be performed by anyone on your staff, MA level or above.
3) Begin to test your patients when they are diagnosed with Type II diabetes and at regular intervals going forward.
4) The Galvanic Skin Test delivers easy-to-read results, enabling patients to get ahead of the serious complications of neuropathy.
5) After 100 patients have been tested and followed-up, your device has been paid for.
Why Have We Heard So Little About Peripheral Neuropathy?
Peripheral Neuropathy is common. It’s estimated that upwards of 20 million Americans suffer from this illness and can occur at any age, but is more common among older adults. A l999 survey found that 8-9% of Medicare recipients have Peripheral Neuropathy as their primary or secondary diagnosis. The annual cost to Medicare exceeds $3.5 billion.
Peripheral neuropathy has always been present, but has not received much attention. Its extent and importance have not yet been adequately recognized, and is apt to be misdiagnosed or thought to be merely a side effect of another disease like diabetes or cancer or kidney failure. The development of new therapies has unfortunately been slow and under-funded.
What Causes Peripheral Neuropathy?
There are many causes of neuropathy. Approximately 30% of neuropathies are “idiopathic,” or of an unknown cause. In another 30% of cases, the cause is diabetes. Other neuropathy causes include autoimmune disorders, tumors, heredity, nutritional imbalances, infections or toxins.
Can Peripheral Neuropathy Be Cured?
Some types of peripheral neuropathy can be cured, and while most cannot, many can still be helped. Therapy is directed at treating the underlying disease and at improving the symptoms with the right medications. An experienced neurologist can help patients feel more comfortable, and their quality of life can be greatly improved. It is extremely important to get to an experienced neurologist as soon as you
notice the symptoms before the disease has a chance to cause extensive,